← All stocks

Definium Therapeutics, Inc.

DFTX Scheduled selling only

CIK 0001813814 #1221 in the set updated 22 Sep 2026

Bought (1 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (1 mo)

$721.73K

$721.73K on a plan · $0.00 straight out of an exercise

Sold at will

$0.00

0 of 1 sales

Net

−$721.73K

$0.00 against sales at will

By person

12 insiders · 3 transactions

130×

Robert Barrow holds 130 times base salary in stock. $85.16M of shares against $655.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Robert Barrow last reported holding, valued at $37.94, the price Common Shares was last bought or sold at on the open market here, on 3 Sep 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Barrow Robert

Chief Executive Officer

—

$721.73K (1) scheduled

−$721.73K

2,244,640

1.67%

$85.16M

+814.4%

Karlin Daniel

Chief Medical Officer

—

803,699

0.5981%

$30.49M

+305.4%

Sullivan Mark

Chief Legal Officer

—

508,279

0.3783%

$19.28M

+798.7%

Roberts Brandi

Chief Financial Officer

—

397,905

0.2961%

$15.10M

+43,245%

Wiley Matthew T.

Chief Commercial Officer

—

362,133

0.2695%

$13.74M

—

Liao Carrie

Chief Accounting Officer

—

144,923

0.1079%

$5.50M

+42.2%

CRYSTAL ROGER

Director

—

24,289

0.0181%

$921.52K

+23.8%

Bruhn Suzanne Louise

Director

—

24,289

0.0181%

$921.52K

+23.8%

Vallone Carol A

Director

—

22,296

0.0166%

$845.91K

+34.8%

Krebs Andreas

Director

—

21,402

0.0159%

$811.99K

+41.7%

GRYSKA DAVID W

Director

—

19,900

0.0148%

$755.01K

+56.3%

Adsett Roger

Director

—

3,555

0.0026%

$134.88K

—

Individual transactions

Insider

Date

Role

Action

Price

Amount

Vallone Carol A

18 Sep 2026

Director

Exercised, kept

1,086

$35.52

$38.57K

Krebs Andreas

18 Sep 2026

Director

Exercised, kept

1,629

$35.52

$57.86K

Show all 3 transactions →

What was left out

Form 4 filings counted 8

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 1

Sales straight out of an exercise 0

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 1,367,715

History held since 19 Jan 2022